From: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Laboratory analysis | DEM-TACE | B-TACE | |||||||
---|---|---|---|---|---|---|---|---|---|
Pre | Post | Fold | p | Pre | Post | fold | p | p∞ | |
AST (IU/L) (median CI 95%) | 36.0 (30.5 – 43.1) | 52.0 (40.5- 65.2) | 1.2 (1.1–1.3) | 0.0009 | 38.0 (24.0–50-0) | 62.5 (42.4–129.5) | 1.2 (0.9–2-1) | 0.001 | 0.84 |
ALT (IU/L) (median CI 95%) | 31.0 (23.5–39-5) | 41.5 (30.0–53-1) | 1.1 (1.0–1.2) | 0.01 | 24.0 (18.8–45-1) | 57–0 (33.0–76-6) | 1.3 (0.6–1-1) | 0.001 | 0.72 |
ALP (IU/L) (median CI 95%) | 112.0 (98.9–118-4) | 106.5 (99.7–116-2) | 0.9 (0.9–1.0) | 0.18 | 120 (86.3–149.9) | 109.0 (91.1–138.7) | 0.9 (0.0–1.1) | 0.10 | 0.55 |
γ-GT (IU/L) (median CI 95%) | 76.5 (58.9–96.7) | 69.0 (54.3–99.0) | 0.9 (0.9–1.0) | 0.08 | 65.5 (30.6–134-0) | 63.0 (55.0–118.9) | 0.9 (0.7–1.1) | 0.85 | 0.72 |
Bilirubin total (mg/dL) (median CI 95%) | 1.0 (1.0–1.1) | 1.2 (0.9–1.4) | 1.1 (1.0–1.3) | 0.1 | 1.0 (0.8–1.3) | 1.5 (0.8–1.9) | 1.2 (0.7–1.3) | 0.001 | 0.75 |
Bilirubin direct (mg/dL) (median CI 95%) | 0.5 (0.4–0.5) | 0.5 (0.5–0.7) | 1.2 (1.0–1.4) | 0.1 | 0.4 (0.3–0.6) | 0.7 (0.4–0.9) | 1.2 (0.8–1.4) | 0.0005 | 0.74 |
Albumin(g/L) (median CI 95%) | 38.0 (35.0–40.5) | 38.0 (34.4) | 0.9 (0.0–0.9) | 0.29 | 38.0 (26.3–41.0) | 36.0 (28.5–41.7) | 0.8 (0.0–1.0) | 0.41 | 0.54 |
Platelet (× 10^3/μL) (median CI 95%) | 93.0 (72.1–113-0) | 90.0 (70.0–107.7) | 1.0 (1.0–1.1) | 0.52 | 75.0 (46.6–103.2) | 65.0 (42.0–99.2) | 1.0 (0.9–1.1) | 0.60 | 1.00 |
Neutrophil (× 10^9/L) (median CI 95%) | 1.6 (1.2–2-1) | 3.3 (2.6–3.6) | 1.7 (1.4–2.2) | < 0.0001 | 2.0 (1.7–2.5) | 3.6 (2.5–5-7) | 2.2 (1.1–3.4) | 0.009 | 0.62 |
INR (median CI 95%) | 1.3 (1.2–1.4) | 1.2 (1.2–1.4) | 1.0 (1.0–1.0) | 0.14 | 1.2 (1.1–1-3) | 1.2 (1.2–1-3) | 1.0 (0.8–1.0) | 0.80 | 0.27 |